Skip to main content
. Author manuscript; available in PMC: 2009 Jan 17.
Published in final edited form as: Vaccine. 2007 Nov 29;26(3):430–439. doi: 10.1016/j.vaccine.2007.10.070

Figure 3. Normal lesion progression and eschar separation following administration of PIO.

Figure 3

(3A) Photographs of a representative subject showing the cutaneous reaction following smallpox revaccination and treatment with povidone-iodine beginning at day 7. (3B) The application of povidone-iodine did not adversely affect healing times and no cases of contact dermatitis occurred.